Sub menu

Vaccines

Comirnaty bivalent Original/Omicron BA.1 (Pfizer) (grey cap) (for use in people aged ≥18 years)

Details for Comirnaty bivalent Original/Omicron BA.1 (Pfizer) (grey cap) (for use in people aged ≥18 years) vaccine and its components.

Recently added

This page was added on 05 October 2023.

Updates made

This page was updated on [date-counter-updated-date]. View history of updates

Sponsor
Pfizer Australia
Administration route
Intramuscular injection
Vaccine group
Adolescent and adult formulations
Description:

COVID-19 vaccine containing nucleoside-modified mRNA encoding the spike glycoproteins of SARS-CoV-2 Wuhan-Hu-1 strain and Omicron BA.1 strain. 

Multidose vial without preservative. Each vial contains 6 doses in 2.25mL. Does not require dilution. 

Each 0.3 mL dose contains:

  • 15 µg mRNA encoding the SARS-CoV-2 Wuhan-Hu-1 spike glycoprotein 
  • 15 µg mRNA encoding the SARS-CoV-2 Omicron BA.1 spike glycoprotein
  • ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315)
  • 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159) 
  • Distearoylphosphatidylcholine (DSPC) 
  • Cholesterol 
  • Trometamol 
  • Trometamol hydrochloride 
  • Sucrose 
  • Water for injections

For Product Information and Consumer Medicine Information about Comirnaty bivalent Original/Omicron BA.1 visit the Therapeutic Goods Administration website.

Additional vaccine information

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Related diseases
COVID-19

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/vaccines/comirnaty-bivalent-originalomicron-ba1-pfizer-grey-cap-for-use-in-people-aged-18-years

All vaccines

Link copied

Link, share or bookmark directly to this section of the page.